ADI
Price
$213.98
Change
-$1.77 (-0.82%)
Updated
May 30 closing price
Capitalization
106.19B
80 days until earnings call
GALT
Price
$1.31
Change
+$0.07 (+5.65%)
Updated
May 30 closing price
Capitalization
82.28M
78 days until earnings call
Interact to see
Advertisement

ADI vs GALT

Header iconADI vs GALT Comparison
Open Charts ADI vs GALTBanner chart's image
Analog Devices
Price$213.98
Change-$1.77 (-0.82%)
Volume$10.92M
Capitalization106.19B
Galectin Therapeutics
Price$1.31
Change+$0.07 (+5.65%)
Volume$175.03K
Capitalization82.28M
ADI vs GALT Comparison Chart
Loading...
ADI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADI vs. GALT commentary
Jun 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADI is a Hold and GALT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 01, 2025
Stock price -- (ADI: $213.98 vs. GALT: $1.31)
Brand notoriety: ADI: Notable vs. GALT: Not notable
ADI represents the Semiconductors, while GALT is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADI: 229% vs. GALT: 98%
Market capitalization -- ADI: $106.19B vs. GALT: $82.28M
ADI [@Semiconductors] is valued at $106.19B. GALT’s [@Biotechnology] market capitalization is $82.28M. The market cap for tickers in the [@Semiconductors] industry ranges from $3.3T to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $303.58B to $0. The average market capitalization across the [@Semiconductors] industry is $52.59B. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADI’s FA Score shows that 2 FA rating(s) are green whileGALT’s FA Score has 0 green FA rating(s).

  • ADI’s FA Score: 2 green, 3 red.
  • GALT’s FA Score: 0 green, 5 red.
According to our system of comparison, ADI is a better buy in the long-term than GALT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADI’s TA Score shows that 4 TA indicator(s) are bullish while GALT’s TA Score has 3 bullish TA indicator(s).

  • ADI’s TA Score: 4 bullish, 6 bearish.
  • GALT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ADI and GALT are a bad buy in the short-term.

Price Growth

ADI (@Semiconductors) experienced а +1.67% price change this week, while GALT (@Biotechnology) price change was +2.34% for the same time period.

The average weekly price growth across all stocks in the @Semiconductors industry was -0.07%. For the same industry, the average monthly price growth was +9.70%, and the average quarterly price growth was +1.44%.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was +0.48%, and the average quarterly price growth was -5.03%.

Reported Earning Dates

ADI is expected to report earnings on Aug 20, 2025.

GALT is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Semiconductors (-0.07% weekly)

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADI($106B) has a higher market cap than GALT($82.3M). GALT YTD gains are higher at: 1.550 vs. ADI (1.154). ADI has higher annual earnings (EBITDA): 4.12B vs. GALT (-40.38M). ADI has more cash in the bank: 2.72B vs. GALT (27.1M). GALT has less debt than ADI: GALT (105M) vs ADI (7.57B). ADI has higher revenues than GALT: ADI (9.34B) vs GALT (0).
ADIGALTADI / GALT
Capitalization106B82.3M128,797%
EBITDA4.12B-40.38M-10,191%
Gain YTD1.1541.55074%
P/E Ratio58.15N/A-
Revenue9.34B0-
Total Cash2.72B27.1M10,041%
Total Debt7.57B105M7,207%
FUNDAMENTALS RATINGS
ADI vs GALT: Fundamental Ratings
ADI
GALT
OUTLOOK RATING
1..100
6391
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
96
Overvalued
PROFIT vs RISK RATING
1..100
27100
SMR RATING
1..100
84100
PRICE GROWTH RATING
1..100
5388
P/E GROWTH RATING
1..100
41100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ADI's Valuation (25) in the Semiconductors industry is significantly better than the same rating for GALT (96) in the Biotechnology industry. This means that ADI’s stock grew significantly faster than GALT’s over the last 12 months.

ADI's Profit vs Risk Rating (27) in the Semiconductors industry is significantly better than the same rating for GALT (100) in the Biotechnology industry. This means that ADI’s stock grew significantly faster than GALT’s over the last 12 months.

ADI's SMR Rating (84) in the Semiconductors industry is in the same range as GALT (100) in the Biotechnology industry. This means that ADI’s stock grew similarly to GALT’s over the last 12 months.

ADI's Price Growth Rating (53) in the Semiconductors industry is somewhat better than the same rating for GALT (88) in the Biotechnology industry. This means that ADI’s stock grew somewhat faster than GALT’s over the last 12 months.

ADI's P/E Growth Rating (41) in the Semiconductors industry is somewhat better than the same rating for GALT (100) in the Biotechnology industry. This means that ADI’s stock grew somewhat faster than GALT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADIGALT
RSI
ODDS (%)
Bearish Trend 2 days ago
55%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
58%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 17 days ago
59%
Bullish Trend 25 days ago
79%
Declines
ODDS (%)
Bearish Trend 9 days ago
58%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
ADI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GALT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZS275.7024.59
+9.79%
Zscaler
FSI4.410.10
+2.32%
Flexible Solutions International
GB7.43-0.01
-0.13%
Global Blue Group Holding AG
NSP64.72-0.49
-0.75%
Insperity
SJT6.28-0.33
-4.99%
San Juan Basin Royalty Trust UBI

ADI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADI has been closely correlated with NXPI. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if ADI jumps, then NXPI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADI
1D Price
Change %
ADI100%
-0.82%
NXPI - ADI
90%
Closely correlated
-2.43%
MCHP - ADI
88%
Closely correlated
-0.12%
TXN - ADI
88%
Closely correlated
-1.16%
ON - ADI
82%
Closely correlated
-2.14%
SLAB - ADI
79%
Closely correlated
-2.63%
More

GALT and

Correlation & Price change

A.I.dvisor indicates that over the last year, GALT has been loosely correlated with BCAB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GALT jumps, then BCAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GALT
1D Price
Change %
GALT100%
+5.65%
BCAB - GALT
37%
Loosely correlated
+4.60%
NVO - GALT
32%
Poorly correlated
+2.94%
SNPX - GALT
32%
Poorly correlated
+0.60%
RNAC - GALT
32%
Poorly correlated
-4.40%
ERAS - GALT
27%
Poorly correlated
-3.45%
More